论文信息 - Early clearance of plasma EGFR mutations as a predictor of response to osimertinib in the AURA3 trial. - 字舞流文

Early clearance of plasma EGFR mutations as a predictor of response to osimertinib in the AURA3 trial.

M. Ahn | Yi-long Wu | F. Shepherd | S. Ramalingam | T. Mok | V. Papadimitrakopoulou | Ji-Youn Han | K. Thress | T. John | G. Oxnard | A. Markovets | W. Theelen | M. Sebastian | G. Laus | B. Collins